Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 68071-3948

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-3948). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3948 3)

Label for Atorvastatin Calcium 40 mg film-coated tablets by NuCare Pharmaceuticals, Inc. The label indicates a package of 30 tablets, with product number P1916030. Tablets are oval, white, with 'LS' debossed on one side and '249' on the other. The label includes barcodes and warnings to keep out of reach of children, with storage instructions at 68-77°F.*

FDA Label Image

Structural Formula (96f45871 7175 49d8 8374 Dfa2978d38c7 01)

Chemical structure of atorvastatin calcium showing the arrangement of its atoms and functional groups, including aromatic rings, hydroxyl groups, and calcium ion coordination with three water molecules of hydration.*

FDA Label Image

Figure1 (96f45871 7175 49d8 8374 Dfa2978d38c7 02)

A line graph depicting cumulative incidence percentage over time in years up to 3.5 years, comparing Atorvastatin with placebo. The Atorvastatin group shows a lower cumulative incidence than the placebo, as represented by a solid line versus a dashed line. The graph includes a hazard ratio (HR) of 0.64 with a p-value of 0.0005.*

FDA Label Image

Figure2 (96f45871 7175 49d8 8374 Dfa2978d38c7 03)

A line graph showing cumulative hazard (%) over time (years) for Atorvastatin versus placebo during up to 5 years of follow-up. The Atorvastatin group has a lower cumulative hazard compared to placebo. Hazard ratio (HR) 0.63 (0.48-0.83), p=0.001 is displayed on the graph.*

FDA Label Image

Figure3 (96f45871 7175 49d8 8374 Dfa2978d38c7 04)

A line chart comparing the percentage of subjects experiencing an event over time for Atorvastatin 10 mg versus 80 mg. The x-axis shows time to first major cardiovascular endpoint in years (0 to 5), and the y-axis shows the percentage of subjects experiencing the event (0 to 0.2%). The 10 mg dose is represented by a dotted line and the 80 mg dose by a solid line, with hazard ratio (HR) 0.78 and p-value 0.0002 noted on the chart.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.